-
Flibanserin: First Global Approval.
Drugs 20151001
-
Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder.
CNS spectrums 20150201
-
The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.
Journal of neural transmission (Vienna, Austria : 1996) 20121101
-
An update on the pharmacological management of female sexual dysfunction.
Expert opinion on pharmacotherapy 20121001
-
Population pharmacokinetic/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers.
Pharmaceutical research 20120601
-
Resurgence of interest in sexual dysfunction?
BJU international 20120601
-
Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
The journal of sexual medicine 20120401
-
Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
The journal of sexual medicine 20120301
-
Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.
The journal of sexual medicine 20120301
-
Isolation and structural elucidation of flibanserin as an adulterant in a health supplement used for female sexual performance enhancement.
Journal of pharmaceutical and biomedical analysis 20120105
-
Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 20111201
-
Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
The journal of sexual medicine 20111201
-
Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
The journal of sexual medicine 20111101
-
[Depressive disorder, treatment and sexual dysfunction--part II].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20111001
-
Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
The journal of sexual medicine 20110501
-
Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.
The journal of sexual medicine 20110101
-
Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.
Molecular brain 20110101
-
Pharmacogenetics of antidepressants.
Frontiers in pharmacology 20110101
-
Consultation corner. The latest on female sexual health.
The Johns Hopkins medical letter health after 50 20101101
-
[The abandonment of the development of flibanserin].
Revue medicale suisse 20101027
-
Boehringer Ingelheim withdraws libido drug for women.
BMJ (Clinical research ed.) 20101012
-
Do drugs have a role in turning indifference into passion?
BMJ (Clinical research ed.) 20101005
-
Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
The journal of sexual medicine 20101001
-
[When women complain about lacking libido. The problem with the desire].
MMW Fortschritte der Medizin 20100902
-
Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100901
-
Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Women's health (London, England) 20100901
-
Dysfunctional women remain unsexed.
BJU international 20100801
-
[Normality of the female libido? (2)].
Revue medicale suisse 20100714
-
Drug for low sexual desire carries significant harms, FDA advisers find.
BMJ (Clinical research ed.) 20100707
-
[Normality of the female libido (1)].
Revue medicale suisse 20100630
-
Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.
Naunyn-Schmiedeberg's archives of pharmacology 20100601
-
FDA advisers to assess drug for low sexual desire in women.
BMJ (Clinical research ed.) 20100525
-
Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study.
The journal of sexual medicine 20100501
-
Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test.
Pharmacology, biochemistry, and behavior 20100501
-
Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.
Frontiers in neuroscience 20100101
-
Management of hypoactive sexual desire disorder in women: current and emerging therapies.
International journal of women's health 20100101
-
A new strategy for antidepressant prescription.
Frontiers in neuroscience 20100101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090501
-
Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells.
The international journal of neuropsychopharmacology 20080501
-
High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity.
Journal of medicinal chemistry 20071004
-
Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors.
Acta neuropathologica 20050401
-
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
The international journal of neuropsychopharmacology 20041201
-
Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.
The Journal of pharmacy and pharmacology 20040101
-
Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.
British journal of pharmacology 20030801
-
Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain.
The international journal of neuropsychopharmacology 20020601
-
Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media.
Pharmaceutical research 20020301
-
Pharmacology of flibanserin.
CNS drug reviews 20020101
-
Mechanism of action of flibanserin in the learned helplessness paradigm in rats.
European journal of pharmacology 20011214
-
Further characterisation of potential antidepressant action of flibanserin.
Psychopharmacology 20011201
-
Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in rats.
The international journal of neuropsychopharmacology 20010301
-
Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
Pharmacological research 20010201
-
Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.
European journal of pharmacology 19971211
